Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer (2020)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-20-0768
PubMed Identifier: 32414837
Publication URI: http://europepmc.org/abstract/MED/32414837
Type: Journal Article/Review
Parent Publication: Cancer Research
Issue: 10
ISSN: 0008-5472